Feature|Videos|February 25, 2026

The Patient-Site Relationship: Why It’s Crucial and How to Support It

Steve Rosenberg, CEO of uMotif, explores the core challenges of clinical trial recruitment and retention, and discusses how digital tools empower sites and patients to build more effective, trust-based relationships.

Key Learning Objectives

  • Understand why the patient-site relationship is pivotal in any clinical trial.
  • Recognize the most promising areas where technologies such as eConsent, eCOA/ePRO, and event-driven eDiaries positively impact clinical trials for patient, sites, and sponsors.
  • Recognize the industry must ensure AI is used to create positive impacts on clinical research and patient health and well-being.

Empathy-driven technology can reduce participant burden and improve trial compliance by strengthening the bond between investigators and patients. Steve Rosenberg, CEO of uMotif, details how the company’s modern, scalable platform supports patient-reported outcomes and efficient site management, which led to the company being named a major contender in the 2025 Everest Group eCOA products assessment. Discover how digital companions and flexible technology are reshaping the future of clinical research to better serve an evolving patient population.


Related to this article

© photon_photo - © photon_photo - stock.adobe.com
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.